×

本司产品仅用于科研,不用于临床诊断和治疗

全国免费热线:400-999-2100

您身边的细胞培养专家!

所有分类
  • 所有分类
  • 细胞系
  • 原代细胞
  • 血清
  • 细胞培养基
  • 辅助试剂
  • 细胞凋亡检测试剂盒
  • 细胞房除菌产品
热搜: 胎牛血清 VERO RAW264.7 成纤维细胞 间充质干细胞 上皮细胞

忘记密码

个人邮箱:
验证码: captcha

账号激活

个人邮箱:
×
当前位置:首页 >> 产品中心 >> 细胞资源库 >> 细胞系 >> 小鼠

产品中心Cell Resources

联系我们CONTACT US

  • LLC [LL/2; LLC1] (小鼠肺癌细胞) (STR鉴定正确)
  • LLC [LL/2; LLC1] (小鼠肺癌细胞) (STR鉴定正确)
  • LLC [LL/2; LLC1] (小鼠肺癌细胞) (STR鉴定正确)
  • LLC [LL/2; LLC1] (小鼠肺癌细胞) (STR鉴定正确)
  • LLC [LL/2; LLC1] (小鼠肺癌细胞) (STR鉴定正确)
  • LLC [LL/2; LLC1] (小鼠肺癌细胞) (STR鉴定正确)
  • LLC [LL/2; LLC1] (小鼠肺癌细胞) (STR鉴定正确)

LLC [LL/2; LLC1] (小鼠肺癌细胞) (STR鉴定正确)

货号:CL-0140

规格:1×10⁶cells/T25培养瓶

价格: ¥1000

生长培养基:DMEM10% FBS1% P/S

数量: - +

  • LLC [LL/2; LLC1] (小鼠肺癌细胞) (STR鉴定正确)
  • LLC [LL/2; LLC1] (小鼠肺癌细胞) (STR鉴定正确)
  • LLC [LL/2; LLC1] (小鼠肺癌细胞) (STR鉴定正确)
  • LLC [LL/2; LLC1] (小鼠肺癌细胞) (STR鉴定正确)
  • LLC [LL/2; LLC1] (小鼠肺癌细胞) (STR鉴定正确)
  • LLC [LL/2; LLC1] (小鼠肺癌细胞) (STR鉴定正确)
  • LLC [LL/2; LLC1] (小鼠肺癌细胞) (STR鉴定正确)

推荐搭配

套餐1:

LLC [LL/2; LLC1] (小鼠肺癌细胞) (STR鉴定正确) ¥1000
LLC [LL/2; LLC1]细胞专用培养基
  • ¥350
  • ¥450

现单独购买该产品也可享受限时优惠价!

细胞培养最优解!

套餐组合价:¥1350¥1450

加入购物车

搭配套餐已成功加入购物车!

产品概述
产品信息
名称 LLC [LL/2; LLC1] (小鼠肺癌细胞) (STR鉴定正确)
别称 LL/2 (LLc1); LL/2(LLc1); LL/2; LL2; LLC1; LLC; Lewis lung carcinoma line 1; Lewis lung carcinoma; Lewis-Lung; Lewis Lung
种属 小鼠
生长特性 半贴半悬
细胞形态 上皮细胞样
冻存条件 冻存液:55% 基础培养基+40%FBS+5%DMSO 温度:液氮
培养方案A(默认)
生长培养基:
培养条件:
气相:空气,95%;CO2,5%, 温度:37℃
推荐传代比例 1:2-1:4
推荐换液频率 2-3次/周
参考资料(来源文献)
背景描述 LLC细胞是小鼠Lewis肺癌细胞。
年龄(性别) 不详
组织来源
细胞类型 肿瘤细胞
肿瘤类型 肺癌细胞
生物安全等级 BSL-1
致瘤性 Yes, in C57BL mice.
抗原表达情况 H-2b
保藏机构 ATCC; CRL-1642 BCRC; 60050 BCRJ; 0145 ECACC; 90020104
STR鉴定
  • STR位点信息
    18-3 15,16
    6-7 15
    5-5 16,17
    X-1 25,26
    1-2 18,19
    7-1 27.2
    8-1 16,17
    1-1 15,16,17,18
    19-2 13
    15-3 24.3,25.3,26.3
    12-1 17
    6-4 18
    4-2 21.3,23.3
    3-2 13,14
    2-1 16
    13-1

    18.1

    11-2 13.3,14.3,15.3
    17-2 14,15
  • STR鉴定图
参考文献
文献列表
  • Oxyhaemoglobin saturation NIR-IIb imaging for assessing cancer metabolism and predicting the response to immunotherapy(2023/09/11)

    作者:Zhiguo Fang, Chenlei Wang, Jingrun Yang

    期刊:Nature Nanotechnology

    DOI:10.1038/s41565-023-01501-4

    影响因子 :38.300

    引用产品:CL-0140

  • A method for predicting drugs that can boost the efficacy of immune checkpoint blockade(2024/03/18)

    作者:Yun Xia, Xin Li, Nana Bie

    期刊:NATURE IMMUNOLOGY

    DOI:10.1038/s41590-024-01789-x

    影响因子 :30.500

    引用产品:CL-0140

  • Generation of whole tumor cell vaccine for on-demand manipulation of immune responses against cancer under near-infrared laser irradiation(2023/07/26)

    作者:Jiaqi Meng, Yanlin Lv, Weier Bao

    期刊:Nature Communications

    DOI:10.1038/s41467-023-40207-y

    影响因子 :16.600

    引用产品:CL-0007 CL-0071 CL-0140

  • Cholesterol removal improves performance of a model biomimetic system to co-deliver a photothermal agent and a STING agonist for cancer immunotherapy(2023/08/22)

    作者:Lin Li, Mengxing Zhang, Jing Li

    期刊:Nature Communications

    DOI:10.1038/s41467-023-40814-9

    影响因子 :16.600

    引用产品:CL-0014 CL-0140 CL-0190 CL-0331

  • UPP1 promotes lung adenocarcinoma progression through the induction of an immunosuppressive microenvironment(2024/02/08)

    作者:Yin Li, Manling Jiang, Ling Aye

    期刊:Nature Communications

    DOI:10.1038/s41467-024-45340-w

    影响因子 :16.600

    引用产品:CL-0140

  • Brain Metastasis from EGFR-Mutated Non-Small Cell Lung Cancer: Secretion of IL11 from Astrocytes Up-Regulates PDL1 and Promotes Immune Escape(2024/05/02)

    作者:Mengyi Tang, Mingxin Xu, Jian Wang

    期刊:Advanced Science

    DOI:10.1002/advs.202306348

    影响因子 :15.100

    引用产品:CL-0140

  • Autologous-cancer-cryoablation-mediated nanovaccine augments systematic immunotherapy(2023/02/21)

    作者:Zhongyang Yu, Dawei Wang, Yuxia Qi

    期刊:Materials Horizons

    DOI:10.1039/D3MH00092C

    影响因子 :13.300

    引用产品:CL-0140

  • Suppression of Tumor or Host Intrinsic CMTM6 Drives Antitumor Cytotoxicity in a PD-L1–Independent Manner(2023/02/03)

    作者:Yiru Long, Runqiu Chen, Xiaolu Yu

    期刊:Cancer Immunology Research

    DOI:10.1158/2326-6066.CIR-22-0439

    影响因子 :10.100

    引用产品:CL-0005 CL-0007 CL-0019 CL-0071 CL-0105 CL-0129 CL-0140 CL-0196 CL-0246 CL-0319

  • Nerve Growth Factor/Tyrosine Kinase A Receptor Pathway Enhances Analgesia in an Experimental Mouse Model of Bone Cancer Pain by Increasing Membrane Levels of δ-Opioid Receptors(2024/03/08)

    作者:Bufan Kan, Xingyun Liu, Mingming Han

    期刊:ANESTHESIOLOGY

    DOI:10.1097/ALN.0000000000004880

    影响因子 :8.800

    引用产品:CL-0140

  • Metal-Phenolic network pH-Sensitive Nanoparticle-Enabled Chemo/Chemodynamic therapy for lung cancer(2023/06/08)

    作者:Daiwang Shi, Siyi Li, Wenhan Liu

    期刊:MATERIALS & DESIGN

    DOI:10.1016/j.matdes.2023.112072

    影响因子 :8.400

    引用产品:CL-0016 CL-0140

  • Luteolin Relieves Lung Cancer-Induced Bone Pain by Inhibiting NLRP3 Inflammasomes and Glial Activation in the Spinal Dorsal Horn in Mice( 2021/12/25)

    作者:Yongsheng Zhou, Yue Cui, Jiaxin Zheng

    期刊:Phytomedicine

    DOI:10.1016/j.phymed.2021.153910

    影响因子 :7.900

    引用产品:CL-0140

  • Hypoxia-induced AFAP1L1 regulates pathological neovascularization via the YAP-DLL4-NOTCH axis(2023/09/22)

    作者:Junsong Ren, Wen Bai, Jingjuan Ding

    期刊:Journal of Translational Medicine

    DOI:10.1186/s12967-023-04503-x

    影响因子 :7.400

    引用产品:CL-0016 CL-0140

  • Erianin inhibits human lung cancer cell growth via PI3K/Akt/mTOR pathway in vitro and in vivo(2021/03/17)

    作者:Huiqiong Zhang, Xiaofang Xie, Gangmin Li

    期刊:Phytotherapy Research

    DOI:10.1002/ptr.7154

    影响因子 :7.200

    引用产品:CL-0003 CL-0016 CL-0140 CL-0298

  • Intelligent triggering of nanomicelles based on a ROS-activated anticancer prodrug and photodynamic therapy (PDT)-synergistic therapy for lung cancers(2022/08/03)

    作者:Lixue Chen, Ruping Xu, Yanfang Ding

    期刊:EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

    DOI:10.1016/j.ejmech.2022.114622

    影响因子 :6.700

    引用产品:CL-0140 CL-0149

  • Radiation-induced bystander effect on the genome of bone marrow mesenchymal stem cells in lung cancer(2022/10/14)

    作者:Yiming Zhang, Liying Zhang, Yangyang Li

    期刊:ANTIOXIDANTS & REDOX SIGNALING

    DOI:10.1089/ars.2022.0072

    影响因子 :6.600

    引用产品:CL-0016 CL-0140 CL-0165 CL-0401

  • DHA/EPA-Enriched Phosphatidylcholine Suppresses Tumor Growth and Metastasis via Activating Peroxisome Proliferator-Activated Receptor γ in Lewis Lung Cancer Mice(2021/01/06)

    作者:Yuanyuan Liu, Yingying Tian, Weizhen Cai

    期刊:Journal Of Agricultural And Food Chemistry

    DOI:10.1021/acs.jafc.0c06890

    影响因子 :6.100

    引用产品:CL-0140

  • Reassembling of albumin-bound paclitaxel mitigates myelosuppression and improves its antitumoral efficacy via neutrophil-mediated targeting drug delivery(2022/02/21)

    作者:Yuxin Chen, Lulu Han, Xiaoyan Qiu

    期刊:Drug Delivery

    DOI:10.1080/10717544.2022.2046892

    影响因子 :6.000

    引用产品:CL-0140

  • Dynamic Changes of the Gut Microbiota and Its Functional Metagenomic Potential during the Development of Non-Small Cell Lung Cancer(2024/03/28)

    作者:Cuijiao Feng, Na Li, Guangqi Gao

    期刊:INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

    DOI:10.3390/ijms25073768

    影响因子 :5.600

    引用产品:CL-0140

  • Bifunctional molecular probe targeting tumor PD-L1 enhances anti-tumor efficacy by promoting ferroptosis in lung cancer mouse model(2024/03/04)

    作者:Chenxu Shao, Xiaoping Yan, Shangjie Pang

    期刊:INTERNATIONAL IMMUNOPHARMACOLOGY

    DOI:10.1016/j.intimp.2024.111781

    影响因子 :5.600

    引用产品:CL-0140

  • Nanomicelle-Microsphere Composite as a Drug Carrier to Improve Lung-Targeting Specificity for Lung Cancer(2022/02/25)

    作者:Qianqian Zhang, Jianwei Bao, Tijie Duan

    期刊:Pharmaceutics

    DOI:10.3390/pharmaceutics14030510

    影响因子 :5.400

    引用产品:CL-0016 CL-0140

  • Shashen-Maidong Decoction inhibited cancer growth under intermittent hypoxia conditions by suppressing oxidative stress and inflammation(2022/09/02)

    作者:Yuying Zheng, Shengchang Yang, Jianchao Si

    期刊:JOURNAL OF ETHNOPHARMACOLOGY

    DOI:10.1016/j.jep.2022.115654

    影响因子 :5.400

    引用产品:CL-0140

  • Jolkinolide B inhibits proliferation or migration and promotes apoptosis of MCF-7 or BT-474 breast cancer cells by downregulating the PI3K-Akt pathway(2021/08/28)

    作者:Yang Wang, Shiyang Shen, Lei Liu

    期刊:Journal Of Ethnopharmacology

    DOI:10.1016/j.jep.2021.114581

    影响因子 :5.400

    引用产品:CL-0140 CL-0149

  • E74‑like ETS transcription factor 5 facilitates cell proliferation through regulating the expression of adenomatous polyposis coli 2 in non‑small cell lung cancer(2023/07/11)

    作者:Jing Wen, Genggeng Qin, Zhaojing Jiang

    期刊:INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE

    DOI:10.3892/ijmm.2023.5278

    影响因子 :5.400

    引用产品:CL-0140

  • Melatonin attenuates bone cancer pain via the SIRT1/HMGB1 pathway(2022/09/17)

    作者:Chengwei Yang, Fang Kang, Xiang Huang

    期刊:NEUROPHARMACOLOGY

    DOI:10.1016/j.neuropharm.2022.109254

    影响因子 :5.300

    引用产品:CL-0140

  • A novel selenium nanocomposite modified by AANL inhibits tumor growth by upregulating CLK2 in lung cancer(2024/05/15)

    作者:Yueyang Zhang, Ying Chen, Bo Wang

    期刊:BIOORGANIC CHEMISTRY

    DOI:10.1016/j.bioorg.2024.107459

    影响因子 :5.100

    引用产品:CL-0140

  • Black phosphorus nanoparticles for dual therapy of non-small cell lung cancer(2022/02/02)

    作者:Zhongxiao Lin, Qiudi Deng, Qi Fang

    期刊:Journal Of Drug Targeting

    DOI:10.1080/1061186X.2022.2032093

    影响因子 :5.016

    引用产品:CL-0140 CL-0165

  • Alterations of lung microbiota in patients with non-small cell lung cancer(2022/03/07)

    作者:Wen Zeng, ChengZhu Zhao, Mengge Yu

    期刊:Bioengineered

    DOI:10.1080/21655979.2022.2045843

    影响因子 :4.900

    引用产品:CL-0140

  • Combinational delivery of TLR4 and TLR7/8 agonist enhanced the therapeutic efficacy of immune checkpoint inhibitors to colon tumor(2024/03/20)

    作者:Mengjiao Wang, Quan Wan, Chenglv Wang

    期刊:MOLECULAR AND CELLULAR BIOCHEMISTRY

    DOI:10.1007/s11010-024-04966-6

    影响因子 :4.300

    引用产品:CL-0140

  • Study the inhibitory effect and mechanism of the ethanol extract of deziyangxin on LLC cells(2023/07/27)

    作者:Yun Yi, Yahui Jiang, Bobo Bai

    期刊:Heliyon

    DOI:10.1016/j.heliyon.2023.e18712

    影响因子 :4.000

    引用产品:CL-0140

  • Transplantation of feces from mice with Alzheimers disease promoted lung cancer growth(2022/01/24)

    作者:Wangyu Bi, Shanglin Cai, Zhongci Hang

    期刊:BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

    DOI:10.1016/j.bbrc.2022.01.078

    影响因子 :3.100

    引用产品:CL-0140

  • Gut microbiome affects the response to immunotherapy in non-small cell lung cancer(2024/04/04)

    作者:Shengnan Ren, Lingxin Feng, Haoran Liu

    期刊:Thoracic Cancer

    DOI:10.1111/1759-7714.15303

    影响因子 :2.900

    引用产品:CL-0140

  • Depression promotes lung carcinoma progression by regulating the tumor microenvironment in tumor-bearing models of C57BL/6J mice(2021/5/29)

    作者:Sainan Cui, Huiyuan Lin, Yongfei Cui 

    期刊:Neuroscience Letters

    DOI:10.1016/j.neulet.2021.135851

    影响因子 :2.500

    引用产品:CL-0140

  • Sambucus adnata Polysaccharide SPS-1 Inhibits Growth of Transplanted Lung Cancer via Polarizing Tumor Associated Macrophage From M2 into M1(2023/07/10)

    作者:Lei Yuan, Yadong Hu

    期刊:Natural Product Communications

    DOI:10.1177/1934578X231182253

    影响因子 :1.800

    引用产品:CL-0140

  • 点击展开收起列表
FAQs

Q:{{item.question}}

A:

暂无数据
产品资料
注:百度浏览器无法支持扫一扫功能,请输入识别码,获取相应产品资料

识别码示意图

确定
邱国娜/胡文君

邱国娜/胡文君

【 上海 】

何帆

何帆

【 陕西、甘肃、宁夏、青海、新疆 】

 熊经理

熊经理

【 海南 】

朱莎莉

朱莎莉

【 湖北 】

刘本佳

刘本佳

【江苏(除南京外)】

章臣雄

章臣雄

【 广州 】

杜焱炜

杜焱炜

【 四川、云南、西藏 】

田博浩

田博浩

【 重庆、贵州 】

石文平

石文平

【 北京、辽宁 】

胡文君

胡文君

【江西】

李荣枫

李荣枫

【 天津、河北、内蒙古、山西 】

陈雨兰

陈雨兰

【 山东 】

尹国文

尹国文

【浙江】

唐小花

唐小花

【 吉林、黑龙江 】

付帅

付帅

【 安徽 】

朱俊宇

朱俊宇

【 河南、广西 】

李庆祖

李庆祖

【 湖南 】

熊志亮

熊志亮

【 深圳 】

梅文强

梅文强

【福建】

林钊光

林钊光

【南京】

微信扫一扫咨询

微信扫一扫咨询

在线客服
关闭
在线咨询

关注微信公众号